Cryochambers are used to induce a
whole body cryotherapeutic response. According to the WHO nomenclature of
medical devices, cryosurgical units for general purpose are covered under UMDNS
code 11-067, 18-051.
Europe
Cryochambers Market is estimated to account for US$ 53.1 Mn in terms of
value in 2019 and is expected to reach US$ 76.5 Mn by the end of 2027.
Europe Cryochambers Market:
Drivers
Increasing number of cryotherapy
establishments is expected to boost growth of Europe cryochambers market over
the forecast period. For instance, Glass House Retreat, a purpose-built spa,
detox and weight loss retreat in the U.K, houses a cryotherapy chamber.
Europe Cryochambers Market:
Opportunities
Development of novel sensors to
monitor the depth of frozen skin tissue is expected to offer a lucrative growth
opportunities for players in the market. For instance, in February 2020,
researchers at University of Ioannina, Greece, reported development of an
optical fiber-array sensor to monitor the depth of frozen skin tissue during
freezing–thawing cycles in cryosurgery.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/3628
Europe Cryochambers Market:
Restraints
Adverse effects of cryotherapy
are expected to hamper growth of Europe cryochambers market. Modern cryogenic
chambers use mixture of 21% oxygen and 79% nitrogen to achieve and maintain the
near-cryogenic temperatures in the system. However, this exposes patients to
variety of risks and physiological hazards of evaporation of tissue water and
oxygen deficiency. Exposure to sub-zero temperatures in cryochambers may lead
to hypothermia, inert gas asphyxiation, frostbites (cold burn), numbness &
irritation of the skin, nerve damage, eye injury from the extreme low
temperatures or even death in rare cases.
Key Takeaways:
Cryochambers segment in Europe
Cryochambers market was valued at US$ 31.3 Mn in 2018 and is expected to reach
US$ 49.4 Mn by 2027 at a CAGR of 5.4% during the forecast period. Increasing
number of non-invasive and minimally-invasive procedures performed every year
is expected to be the major driving force for the segment growth in the near
future. Factors such as presence of established cryotherapy companies, presence
of skilled professionals, and increasing awareness about the therapy is
expected to support growth of the segment.
The Dermatology & Beauty
Applications segment held dominant position in Europe cryochambers market in
2018, accounting for 46.7% share in terms of value, followed by Sports Medicine
& Pain Management and Others, respectively. The demand for non-invasive and
minimally invasive procedures is increasing exponentially owing to increasing
consumer preference on enhancing one’s physically features, and treating skin
problems. The incidence of both non-melanoma and melanoma skin cancers has been
increasing over the past decades. According to the World Health Organization’s
2018 health statistics, around 2 to 3 million cases of non-melanoma skin
cancers, and 132,000 melanoma skin cancers occur globally each year.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/europe-cryochambers-market-3628
Market Trends
Cryotherapy can be effective
during knee replacement surgery to maintain the surgical area at the desired
temperature. Moreover, postoperative cryotherapy can aid in reducing pain,
bleeding, length of stay, analgesic requirement and swelling after total knee
arthroplasty.
Use of whole-body cryotherapy can
aid reducing blood levels of asprosin in menopausal women. Moreover,
cryotherapy does not significantly affect insulin concentration or insulin
resistance.
Europe Cryochambers Market:
Competitive Landscape
Major players in Europe
cryochambers include, Zimmer MedizinSysteme GmbH, KrioSystem Sp. z.o.o, Air
Products and Chemicals, Inc., CSA Medical, Inc., METRUM CRYOFLEX Sp. z o.o.,
Sp. K., Novotech S.R.O, CryoAction Limited, JUKA SP. Z.O.O. SP.K., Cryosense,
and CRYO Science.
Europe Cryochambers Market: Key
Developments
August 2019: BTG International
Canada Inc., a part of BTG plc., a global specialist healthcare company,
received a medical device license from Health Canada for the ICEfx Cryoablation
System
January 2019: CRYO Science, in
partnership with Canopy Environmental, announced that the U.S. Air Force's
special tactical unit incorporated the CRYO Arctic Whole Body Cryotherapy
Chamber into their squadron at Joint Base Lewis-McChord, Washington
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/3628
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment